Found: 71
Select item for more details and to access through your institution.
Mpox Hepatic and Pulmonary Lesions in HIV/Hepatitis B Virus Co-Infected Patient, France.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 11, p. 2445, doi. 10.3201/eid3011.241331
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 Neutralizing Responses in Various Populations: Use of a Rapid Surrogate Lateral Flow Assay and Correlations with Anti-RBD Antibody Levels.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 7, p. 791, doi. 10.3390/life14070791
- By:
- Publication type:
- Article
SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 12, p. 2064, doi. 10.3390/life12122064
- By:
- Publication type:
- Article
Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients.
- Published in:
- Clinical Kidney Journal, 2022, v. 15, n. 9, p. 1785, doi. 10.1093/ckj/sfac137
- By:
- Publication type:
- Article
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01296-0
- By:
- Publication type:
- Article
Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-024-01296-0
- By:
- Publication type:
- Article
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
- Published in:
- 2018
- By:
- Publication type:
- journal article
P-149: Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S117, doi. 10.1016/S2152-2650(21)02276-X
- By:
- Publication type:
- Article
Efficacy of Etravirine for Treatment of Acute HIV Meningoencephalitis.
- Published in:
- Clinical Infectious Diseases, 2009, v. 48, n. 6, p. e62, doi. 10.1086/597109
- By:
- Publication type:
- Article
Plasma Human Immunodeficiency Virus RNA Below 40 Copies/mL Is Rare in Untreated Persons Even in the First Years of Infection.
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 2
- By:
- Publication type:
- Article
Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected Persons.
- Published in:
- Journal of Infectious Diseases, 1999, v. 179, n. 4
- By:
- Publication type:
- Article
The Risk of Disease Progression Is Determined during the First Year of Human Immunodeficiency Virus Type 1 Infection.
- Published in:
- Journal of Infectious Diseases, 1998, v. 177, n. 6, p. 1541, doi. 10.1086/515308
- By:
- Publication type:
- Article
Full or Partial Seroreversion in Patients Infected by Hepatitis C Virus.
- Published in:
- Journal of Infectious Diseases, 1997, v. 175, n. 2, p. 316
- By:
- Publication type:
- Article
Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: evidence of sexual and parenteral transmission.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1380, doi. 10.1093/jac/dkae112
- By:
- Publication type:
- Article
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1510, doi. 10.1093/jac/dkad119
- By:
- Publication type:
- Article
Erratum to: Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2021, v. 76, n. 11, p. 3070, doi. 10.1093/jac/dkab295
- By:
- Publication type:
- Article
Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
- Published in:
- 2020
- By:
- Publication type:
- journal article
Variability of the HIV-1 3' polypurine tract (3'PPT) region and implication in integrase inhibitor resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2018, v. 73, n. 4, p. 1039, doi. 10.1093/jac/dkx511
- By:
- Publication type:
- Article
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
- Published in:
- Intensive Care Medicine Experimental, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40635-023-00536-0
- By:
- Publication type:
- Article
Author Correction: Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33801-z
- By:
- Publication type:
- Article
Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1--Infected Adults with Viral Suppression Receiving a Protease Inhibitor--Based Regimen: A Randomized Trial.
- Published in:
- Journal of Infectious Diseases, 2005, v. 191, n. 6, p. 830
- By:
- Publication type:
- Article
Pharmacogenetics of Toxicity, Plasma Trough Concentration and Treatment Outcome with Nevirapine-Containing Regimen in Anti-Retroviral-Naïve HIV-Infected Adults: An Exploratory Study of the TRIANON ANRS 081 Trial.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2011, v. 109, n. 6, p. 513, doi. 10.1111/j.1742-7843.2011.00780.x
- By:
- Publication type:
- Article
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression.
- Published in:
- 2016
- By:
- Publication type:
- journal article
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 2084, doi. 10.1093/jac/dkv049
- By:
- Publication type:
- Article
Ultradeep sequencing in the therapeutic management of HIV-1 infection at treatment initiation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1919, doi. 10.1093/jac/dkv013
- By:
- Publication type:
- Article
Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 5, p. 1503, doi. 10.1093/jac/dku557
- By:
- Publication type:
- Article
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 5, p. 1507, doi. 10.1093/jac/dku535
- By:
- Publication type:
- Article
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2588, doi. 10.1093/jac/dku155
- By:
- Publication type:
- Article
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001–2011.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 11, p. 2626
- By:
- Publication type:
- Article
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2197
- By:
- Publication type:
- Article
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2199, doi. 10.1093/jac/dkt200
- By:
- Publication type:
- Article
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1400
- By:
- Publication type:
- Article
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2487
- By:
- Publication type:
- Article
Risk factors for raltegravir resistance development in clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2494, doi. 10.1093/jac/dks254
- By:
- Publication type:
- Article
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 6, p. 1470, doi. 10.1093/jac/dks052
- By:
- Publication type:
- Article
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 12, p. 2827, doi. 10.1093/jac/dkr389
- By:
- Publication type:
- Article